FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885192271> ?p ?o ?g. }

• W2885192271 abstract "The most frequent genetic alterations in melanoma are gain-of-function mutations in BRAF, which result in addiction to RAF-MEK-ERK signaling. Given the centrality of this pathway in many cancers, inhibitors have been developed against various nodes in this signaling axis. Despite the success of these inhibitors in treating BRAFV600E mutant tumors, a major problem is the inevitable emergence of drug resistance. The mechanisms of acquired resistance often include reactivation of the MAPK pathway, thus efforts to combat resistance have used vertical combination strategies to inhibit multiple nodes of the pathway. Previous work from our group showed that vemurafenib-resistant melanoma tumors displayed increased levels of MAPK signaling as indicated by elevated phospho-ERK. Strikingly, cell lines derived from these resistant tumors were addicted to vemurafenib, and removal of drug caused loss in cell viability. Consistently, in vivo, the tumors regressed upon cessation of drug treatment, which was accompanied by elevated MAPK signaling. Recent studies have reported similar results for in vitro models of melanoma resistant to MAPK inhibitors, which are addicted to drug in an ERK2-dependent manner. Together these data suggest that extreme levels of MAPK signaling are not tolerated by tumor cells. To further characterize this phenomenon, we generated models of inducible MAPK hyperactivation in BRAFV600E melanoma cells. Using these model systems, we confirmed that increasing the levels of MAPK signaling can hinder tumor cell proliferation, and demonstrated that MAPK inhibitors can rescue this phenotype. Intriguingly, the effect of MAPK hyperactivation varied depending on the RAS/RAF mutation status of the tumor cells. Upon induction of MAPK hyperactivation in sensitive cells, there was no cell cycle arrest, but instead cell death occurred, which was accompanied by activation of caspases. On a global level, MAPK hyperactivation resulted in transcriptome changes that were opposite to those produced by treatment with an ERK inhibitor. This phenomenon of MAPK hyperactivation-induced cell death was also observed in vivo, where complete tumor regression was observed in a xenograft model. Ongoing studies seek to further define the mechanism of cell death, which could suggest potential avenues to leverage hyperactivation of MAPK signaling as a therapeutic approach. Citation Format: Grace P. Leung, Tianshu Feng, Matthew D. Shirley, Frederic D. Sigoillot, David A. Ruddy, Alyson K. Freeman, Mariela Jaskelioff, Darrin D. Stuart. Deleterious effects of MAPK pathway hyperactivation in BRAF-mutant melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 965." @default.
• W2885192271 created "2018-08-22" @default.
• W2885192271 creator A5017572224 @default.
• W2885192271 creator A5045089083 @default.
• W2885192271 creator A5047953084 @default.
• W2885192271 creator A5049448904 @default.
• W2885192271 creator A5049772515 @default.
• W2885192271 creator A5069634653 @default.
• W2885192271 creator A5080932337 @default.
• W2885192271 creator A5088831762 @default.
• W2885192271 date "2018-07-01" @default.
• W2885192271 modified "2023-09-25" @default.
• W2885192271 title "Abstract 965: Deleterious effects of MAPK pathway hyperactivation in BRAF-mutant melanoma" @default.
• W2885192271 doi "https://doi.org/10.1158/1538-7445.am2018-965" @default.
• W2885192271 hasPublicationYear "2018" @default.
• W2885192271 type Work @default.
• W2885192271 sameAs 2885192271 @default.
• W2885192271 citedByCount "0" @default.
• W2885192271 crossrefType "proceedings-article" @default.
• W2885192271 hasAuthorship W2885192271A5017572224 @default.
• W2885192271 hasAuthorship W2885192271A5045089083 @default.
• W2885192271 hasAuthorship W2885192271A5047953084 @default.
• W2885192271 hasAuthorship W2885192271A5049448904 @default.
• W2885192271 hasAuthorship W2885192271A5049772515 @default.
• W2885192271 hasAuthorship W2885192271A5069634653 @default.
• W2885192271 hasAuthorship W2885192271A5080932337 @default.
• W2885192271 hasAuthorship W2885192271A5088831762 @default.
• W2885192271 hasConcept C2776131300 @default.
• W2885192271 hasConcept C2777658100 @default.
• W2885192271 hasConcept C2778366672 @default.
• W2885192271 hasConcept C2994587330 @default.
• W2885192271 hasConcept C502942594 @default.
• W2885192271 hasConcept C57074206 @default.
• W2885192271 hasConcept C62478195 @default.
• W2885192271 hasConcept C71924100 @default.
• W2885192271 hasConcept C86803240 @default.
• W2885192271 hasConcept C95444343 @default.
• W2885192271 hasConceptScore W2885192271C2776131300 @default.
• W2885192271 hasConceptScore W2885192271C2777658100 @default.
• W2885192271 hasConceptScore W2885192271C2778366672 @default.
• W2885192271 hasConceptScore W2885192271C2994587330 @default.
• W2885192271 hasConceptScore W2885192271C502942594 @default.
• W2885192271 hasConceptScore W2885192271C57074206 @default.
• W2885192271 hasConceptScore W2885192271C62478195 @default.
• W2885192271 hasConceptScore W2885192271C71924100 @default.
• W2885192271 hasConceptScore W2885192271C86803240 @default.
• W2885192271 hasConceptScore W2885192271C95444343 @default.
• W2885192271 hasLocation W28851922711 @default.
• W2885192271 hasOpenAccess W2885192271 @default.
• W2885192271 hasPrimaryLocation W28851922711 @default.
• W2885192271 hasRelatedWork W2000876153 @default.
• W2885192271 hasRelatedWork W2050194585 @default.
• W2885192271 hasRelatedWork W2105317859 @default.
• W2885192271 hasRelatedWork W2328771497 @default.
• W2885192271 hasRelatedWork W2331291943 @default.
• W2885192271 hasRelatedWork W2481729799 @default.
• W2885192271 hasRelatedWork W3034913290 @default.
• W2885192271 hasRelatedWork W3045209127 @default.
• W2885192271 hasRelatedWork W3131108980 @default.
• W2885192271 hasRelatedWork W4283643259 @default.
• W2885192271 isParatext "false" @default.
• W2885192271 isRetracted "false" @default.
• W2885192271 magId "2885192271" @default.
• W2885192271 workType "article" @default.